focus -WSS

focus

author：hotspot 2025-10-01 04:10:49 - browse：17414

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Ransomware attacks on hospitals: Study outlines patient impact

explore

WSS

Poor hospice wound care hurts patients and families

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Physician assistants need a new name. Here's what it should be

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

At JPM 2024, hospital systems pitch financial strength to investors

Morphosys mixed study results for blood cancer drug

leisure time

focus

Why are there no human clones?

focus

In age of alternative facts, a scholarly course on calling out crap

STAT Virtual Event: JPM Recap, Live!

Tori Bowie and the unacceptable rates of Black maternal death

Morphosys mixed study results for blood cancer drug

United colonoscopy coverage change 'may cost lives,' doctors say

Childhood cancer progress stalls for Black, Hispanic kids: Report

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Physician assistants need a new name. Here's what it should be

BioMarin wins approval for gene therapy to treat hemophilia A

Gain of function research would be limited under House proposal

leisure time

JPM pitch from hospitals? Revenue streams outside of patient care

FDA's Woodcock to retire early next year

Hospitals look to new technology to keep health care workers safe

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Morphosys mixed study results for blood cancer drug

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

hotspot

explore

knowledge

focus